Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
A pragmatic, single blinded, randomized, controlled non-inferiority trial of Cytisine versus
Nicotine Replacement Therapy for continuous abstinence is conducted in the government run
primary health hospitals in Mongolia.
Phase:
Phase 3
Details
Lead Sponsor:
Loma Linda University
Collaborators:
Mongolian National University of Medical Sciences Pfizer